Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/91393
標題: A nanoporous small Anodic Aluminum Oxide (AAO) tube for long-acting drug release
具長效藥物釋放功能之奈米孔洞陽極氧化鋁管
作者: 李寶英
Bao-Ying Lee
關鍵字: nanoporous anodic aluminum oxide tube;microporous chitosan/collagen composite;long-acting drug release;MC3T3-E1 differentiation induction;陽極氧化鋁膜;幾丁聚醣;冷凍乾燥;藥物釋放;前趨骨母細胞誘導分化
引用: [1] Y. Qiu and K. Park, 'Environment-sensitive hydrogels for drug delivery,' Adv Drug Deliv Rev, vol. 53, pp. 321-39, 2001. [2] E. M. Ahmed, 'Hydrogel: Preparation, characterization, and applications: A review,' J Adv Res, vol. 6, pp. 105-21, 2015. [3] Z. Ahmad, A. Shah, M. Siddiq, and H. B. Kraatz, 'Polymeric micelles as drug delivery vehicles,' Rsc Advances, vol. 4, pp. 17028-17038, 2014. [4] W. B. Liechty, D. R. Kryscio, B. V. Slaughter, and N. A. Peppas, 'Polymers for drug delivery systems,' Annu Rev Chem Biomol Eng, vol. 1, pp. 149-73, 2010. [5] Slowing, II, J. L. Vivero-Escoto, C. W. Wu, and V. S. Lin, 'Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers,' Adv Drug Deliv Rev, vol. 60, pp. 1278-88, 2008. [6] E. Jimi, S. Hirata, K. Osawa, M. Terashita, C. Kitamura, and H. Fukushima, 'The current and future therapies of bone regeneration to repair bone defects,' Int J Dent, vol. 2012, p. 148261, 2012. [7] K. J. Burg, S. Porter, and J. F. Kellam, 'Biomaterial developments for bone tissue engineering,' Biomaterials, vol. 21, pp. 2347-59, 2000. [8] A. R. Amini, C. T. Laurencin, and S. P. Nukavarapu, 'Bone tissue engineering: recent advances and challenges,' Crit Rev Biomed Eng, vol. 40, pp. 363-408, 2012. [9] S. Bose, M. Roy, and A. Bandyopadhyay, 'Recent advances in bone tissue engineering scaffolds,' Trends Biotechnol, vol. 30, pp. 546-54, 2012. [10] J. Zhang, H. Zhou, K. Yang, Y. Yuan, and C. Liu, 'RhBMP-2-loaded calcium silicate/calcium phosphate cement scaffold with hierarchically porous structure for enhanced bone tissue regeneration,' Biomaterials, vol. 34, pp. 9381-92, 2013. [11] F. Yang, J. Wang, J. Hou, H. Guo, and C. Liu, 'Bone regeneration using cell-mediated responsive degradable PEG-based scaffolds incorporating with rhBMP-2,' Biomaterials, vol. 34, pp. 1514-28, 2013. [12] H. Masuda and K. Fukuda, 'Ordered metal nanohole arrays made by a two-step replication of honeycomb structures of anodic alumina,' Science, vol. 268, pp. 1466-8, 1995. [13] A. M. M. Jani, D. Losic, and N. H. Voelcker, 'Nanoporous anodic aluminium oxide: Advances in surface engineering and emerging applications,' Progress in Materials Science, vol. 58, pp. 636-704, 2013. [14] D. W. Gong, V. Yadavalli, M. Paulose, M. Pishko, and C. A. Grimes, 'Controlled molecular release using nanoporous alumina capsules,' Biomedical Microdevices, vol. 5, pp. 75-80, 2003. [15] B. Y. Yoo, R. K. Hendricks, M. Ozkan, and N. V. Myung, 'Three-dimensional alumina nanotemplate,' Electrochimica Acta, vol. 51, pp. 3543-3550, 2006. [16] H. G. Shin, Y. M. Park, B. H. Kim, and Y. H. Seo, 'Fabrication of Hemispherical Nano Structure on a Curved Al Surface Using Low-Temperature and High-Voltage Anodizing Method,' Journal of Nanoscience and Nanotechnology, vol. 11, pp. 427-431, 2011. [17] L. Zaraska, G. D. Sulka, J. Szeremeta, and M. Jaskula, 'Porous anodic alumina formed by anodization of aluminum alloy (AA1050) and high purity aluminum,' Electrochimica Acta, vol. 55, pp. 4377-4386, 2010. [18] M. Michalska-Domanska, M. Norek, W. J. Stepniowski, and B. Budner, 'Fabrication of high quality anodic aluminum oxide (AAO) on low purity aluminum-A comparative study with the AAO produced on high purity aluminum,' Electrochimica Acta, vol. 105, pp. 424-432, 2013. [19] P. Erdogan, B. Yuksel, and Y. Birol, 'Effect of chemical etching on the morphology of anodic aluminum oxides in the two-step anodization process,' Applied Surface Science, vol. 258, pp. 4544-4550, 2012. [20] Br, #xfc, and D. ggemann, 'Nanoporous Aluminium Oxide Membranes as Cell Interfaces,' Journal of Nanomaterials, vol. 2013, p. 18, 2013. [21] 王英翔(2011), '圖案化陽極氧化鋁膜之藥物釋放應用,' 國立中興大學,機械工程學系,研究所碩士論文,台中市. [22] G. E. Poinern, D. Fawcett, Y. J. Ng, N. Ali, R. K. Brundavanam, and Z. T. Jiang, 'Nanoengineering a biocompatible inorganic scaffold for skin wound healing,' J Biomed Nanotechnol, vol. 6, pp. 497-510, 2010. [23] M. Rinaudo, 'Chitin and chitosan: Properties and applications,' Progress in Polymer Science, vol. 31, pp. 603-632, 2006. [24] F. L. Mi, S. S. Shyu, Y. B. Wu, S. T. Lee, J. Y. Shyong, and R. N. Huang, 'Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing,' Biomaterials, vol. 22, pp. 165-173, 2001. [25] H. W. Kang, Y. Tabata, and Y. Ikada, 'Fabrication of porous gelatin scaffolds for tissue engineering,' Biomaterials, vol. 20, pp. 1339-44, 1999. [26] J. S. Mao, L. G. Zhao, Y. J. Yin, and K. D. Yao, 'Structure and properties of bilayer chitosan-gelatin scaffolds,' Biomaterials, vol. 24, pp. 1067-74, 2003. [27] H. Tan, J. Wu, L. Lao, and C. Gao, 'Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering,' Acta Biomater, vol. 5, pp. 328-37, 2009. [28] M. Alizadeh, F. Abbasi, A. B. Khoshfetrat, and H. Ghaleh, 'Microstructure and characteristic properties of gelatin/chitosan scaffold prepared by a combined freeze-drying/leaching method,' Mater Sci Eng C Mater Biol Appl, vol. 33, pp. 3958-67, 2013. [29] L. P. Yan, Y. J. Wang, L. Ren, G. Wu, S. G. Caridade, J. B. Fan, et al., 'Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications,' J Biomed Mater Res A, vol. 95, pp. 465-75, 2010. [30] E. Salter, B. Goh, B. Hung, D. Hutton, N. Ghone, and W. L. Grayson, 'Bone tissue engineering bioreactors: a role in the clinic?,' Tissue Eng Part B Rev, vol. 18, pp. 62-75, 2012. [31] M. Senba, K. Kawai, and N. Mori, 'Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State,' Leuk Res Treatment, vol. 2012, p. 128617, 2012.
摘要: 
The objective of this study is to develop a long-acting and implantable drug-release device that can effectively control the release rate and concentration of the loaded drug. The proposed device consists of a tubular nanoporous anodic aluminum oxide (AAO) encapsulating a microporous chitosan/collagen composite. The nanopore size of the AAO tube can be modified by adjusting the anodization parameters, which in turn adjust the release rate and concentration, while the microporous chitosan/collagen composite provides the long-acting release feature. Fabrication results indicate that the AAO tube has a uniform pore arrangement with a pore size around 50 nm. The synthesized microporous chitosan/collagen composite containing 90% chitosan yielded the highest moisture content and was therefore used as the drug carrier. Release experiments demonstrate that the proposed long-acting drug-release device had released less than 65% of the loading drug on the 17th release day.
We then applied the proposed long-acting drug-release scheme as a recombinant human-bone morphogenetic-protein 2 (rh-BMP2) release device to induce differentiation of pre-osteoblast MC3T3-E1 cells into osteoblasts. Results from alkaline phosphate (ALP) and alizarin red S assays demonstrate that the total amount of rh-BMP2 consumed by the proposed AAO tube is much less than that consumed using the conventional culture approach. Furthermore, our approach has the advantage of requiring only one-time dosing, whereas the conventional approach requires the periodic renewal of rh-BMP2. AAO's one-time dosing feature combined with its biocompatablity and biodegradability can be beneficial in real implant applications.

本研究開發出一新型低成本且具長效型之奈微米藥物釋放裝置,其主要由具奈米孔洞之陽極氧化鋁圓管以及具微米孔洞之幾丁聚醣/膠原蛋白薄膜所組成。首先,以不銹鋼外環電極為陰極,並於外環電極中心處以橫置放方式將放置純度98.6%之3003鋁錳銅合金管置中,封裝後接上陽極以進行環型陽極氧化製程,以0.3 M之草酸為蝕刻液,於溫度0C之工作環境下施以30 V之定電壓,進行陽極氧化製程24小時,經移除未氧化之鋁合金後再以濃度為之30%之H3PO4去除背阻障層,產生具貫穿之奈米孔洞之陽極氧化鋁管。接著以冷凍乾燥法製作具微米孔洞之幾丁聚醣/膠原蛋白薄膜。最後,將經冷凍乾燥後之幾丁聚醣/膠原蛋白薄膜將做為藥物包埋之載體,包埋藥物後並置入具奈米孔洞陽極氧化鋁管中後,進行封裝完成本裝置。
本研究所製備出之陽極氧化鋁管其孔洞排列與大小具均勻性其平均孔徑約為50 nm,而幾丁聚醣/膠原蛋白薄膜藉由調整兩者不同混和比例可製備出最大173.12±26.89 μm以及最小34.20±8.0 7μm之微米孔洞。包埋於幾丁聚醣/膠原蛋白薄膜內之藥物將透過陽極氧化鋁管上之奈米孔洞控制其釋放之速率,進而達到緩釋的效果。本裝置以濃度0.5%之牛血清蛋白(bovine serum albumin)做為釋放藥物,實驗結果發現於37C環境下,本裝置可藉由奈/微米孔洞之相互配合,使釋放時間達兩週。
另外,本研究將藥物釋放裝置應用於骨組織再生,以可誘導前趨骨母細胞 (pre-osteoblast) MC3T3-E1分化成成骨細胞之生長因子rh-BMP2做為藥物,填充於幾丁聚醣/膠原蛋白複合束後再包覆於具奈米孔洞之陽極氧化鋁圓管中,進行細胞培養實驗。經由鹼性磷酸脢活性測試(ALP)以及茜素紅染色(ARS)實驗發現以rh-BMP2培養之前趨骨母細胞確實能分化為成骨細胞。由茜素紅染色實驗比較出本裝置在細胞培養過程中可以用較低劑量的生長因子,並且透過一次性的投藥即可促進細胞分化為成骨細胞。倘若未來可進一步將本研究之藥物釋放裝置應用於體內藥物釋放,除了具有生物可降解性外也有一次性投藥的優點,因此可以改善舊型裝置需要重複開刀進行藥物補充的缺點。
URI: http://hdl.handle.net/11455/91393
Rights: 不同意授權瀏覽/列印電子全文服務
Appears in Collections:機械工程學系所

Files in This Item:
File Description SizeFormat Existing users please Login
nchu-104-7102061077-1.pdf11.23 MBAdobe PDFThis file is only available in the university internal network   
Show full item record
 

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.